Clinical Trial Update: Glutamate Excitotoxicity and Its Role in Glioblastoma Biology

View source ↗

Summary

A clinical trial investigating the role of glutamate excitotoxicity in glioblastoma biology is currently recruiting, sponsored by IRCCS San Raffaele.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Brain Tumor, Primary | Status: RECRUITING